Ipsen Completes Acquisition of Epizyme Expanding Its Portfolio in Oncology
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
📰 Registration Document News
Page 93 - Registration Document News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Registration Document. Real-time updates on events, politics, business and more.
CREDIT AGRICOLE SA : Results second quarter and first half 2022 - Results: +18.1%; robust activity and stronger capital position
CAG AND CRÉDIT AGRICOLE S.A. STATED AND UNDERLYING RESULTS Q2-2022Results: +18.1%; robust activity and stronger capital position ... | August 4, 2022
Source: marketscreener.com
Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde® in Second-Line Monotherapy for Small Cell Lung Cancer
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
TotalEnergies SE: Floating Offshore Wind in France: TotalEnergies, Corio Generation and Qair Join Forces to Bid for Mediterranean Tender
Regulatory News: A consortium of TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE), Corio Generation and Qair has been pre-selected by the French Directorate General for Energy and Climate (DGEC) to
Source: finanznachrichten.de
Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde in Second-Line Monotherapy for Small Cell Lung Cancer
At the primary analysis, the trial did not meet its primary endpoint of overall survival (OS) The safety profile was consistent with previously reported studies of Onivyde (irinotecan liposomal
Source: finanznachrichten.de
Ipsen and Marengo Therapeutics Announce Strategic Partnership to Advance Two Precision Immuno-Oncolo
Multi-year collaboration will sustain Ipsen’s presence in oncology by leveraging Marengo’s novel discovery of TCR Vβ-targeted precision T cell activation approachIpsen to pay Marengo $45 million upfront with potential for additional milestone paymentsPARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News:Ipsen (...
Source: pharmiweb.com
ProVen VCT plc: Fundraising update - expected close of
ProVen VCT plc Fundraising update - expected close of Offer 1 August 2022 ProVen VCT plc (the "Company") is pleased to announce that the offer for...
Shane Elliott Securities Note Registration Document Financial Advisers Financial Adviser London Stock Exchange Pvn
Source: globenewswire.com
Investegate |Proven VCT plc Announcements | Proven VCT plc: ProVen VCT plc: Fundraising update
Investegate announcements from Proven VCT plc, ProVen VCT plc: Fundraising update - expected close of Offer
Shane Elliott Securities Note Registration Document Financial Advisers Financial Adviser Investegate Announcements
Source: investegate.co.uk
ProVen Growth and Income VCT plc: Fundraising update -
ProVen Growth and Income VCT plc Fundraising update - expected close of Offer 1 August 2022 ProVen Growth and Income VCT plc (the "Company") is pleased...
Source: globenewswire.com
Sopra Steria: H1 2022 Results - 28.07.2022
28.07.2022 - Regulatory News: At its meeting on 27 July 2022, Sopra Steria’s (Paris:SOP) Board of Directors, chaired by Pierre Pasquier, approved the financial statements for the first half of 2022. The Statutory Auditors have conducted a limited review of the ...
United Kingdom Sopra Steria Cyril Malarg Property Management Solutions Sopra Steria Group Sopra Banking Software
Source: wallstreet-online.de